Biophysical studies in polymer therapeutics: the interactions of anionic and cationic PAMAM dendrimers with lipid monolayers

References

• Svenson S. Dendrimers as versatile platform in drug delivery applications. Eur J Pharm Biopharm. 2009;71:445–462.
   PubMed Web of Science ®Google Scholar
• Tomalia DA, Naylor AM, Goddard WA. Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl. 1990;29:138–175.
   Web of Science ®Google Scholar
• Jedrych M, Borowska K, Galus R, et al. The evaluation of the biomedical effectiveness of poly(amido)amine dendrimers generation 4.0 as a drug and as drug carriers: a systematic review and meta-analysis. Int J Pharm. 2014;462:38–43.
   PubMed Web of Science ®Google Scholar
• Yabbarov NG, Posypanova GA, Vorontsov EA, et al. Targeted delivery of doxorubicin: drug delivery system based on PAMAM dendrimers. Biochem Moscow. 2013;78:884–894.
   PubMed Web of Science ®Google Scholar
• Gajbhiye V, Palanirajan VK, Tekade RK, et al. Dendrimers as therapeutic agents: a systematic review. J Pharm Pharmacol. 2009;61:989–1003.
   PubMed Web of Science ®Google Scholar
• Shcharbin D, Shakhbazau A, Bryszewska M. Poly(amidoamine) dendrimer complexes as a platform for gene delivery. Expert Opin Drug Deliv. 2013;10:1687–1698.
   PubMed Web of Science ®Google Scholar
• Yu S, Li MH, Choi SK, et al. DNA condensation by partially acetylated poly(amido amine) dendrimers: effects of dendrimer charge density on complex formation. Molecules. 2013;18:10707–10720.
   PubMed Web of Science ®Google Scholar
• Zhong H, He ZG, Li Z, et al. Studies on polyamidoamine dendrimers as efficient gene delivery vector. J Biomater Appl. 2008;22:527–544.
   PubMed Web of Science ®Google Scholar
• Sadekar S, Ghandehari H. Transepithelial transport and toxicity of PAMAM dendrimers: implications for oral drug delivery. Adv Drug Deliv Rev. 2012;64:571–588.
   PubMed Web of Science ®Google Scholar
• Mukherjee SP, Davoren M, Byrne HJ. In vitro mammalian cytotoxicological study of PAMAM dendrimers – towards quantitative structure activity relationships. Toxicol In Vitro. 2010;24:169–177.
   Google Scholar
• Duncan R, Izzo L. Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev. 2005;57:2215–2237.
   PubMed Web of Science ®Google Scholar
• Kumar A, Yellepeddi VK, Davies GE, et al. Enhanced gene transfection efficiency by polyamidoamine (PAMAM) dendrimers modified with ornithine residues. Int J Pharm. 2010;392:294–303.
   PubMed Web of Science ®Google Scholar
• Albertazzi LA, Serresi M, Albanese A, et al. Dendrimer internalization and intracellular trafficking in living cells. Mol Pharm. 2010;7:680–688.
   PubMed Web of Science ®Google Scholar
• Wang S, Li Y, Fan J, et al. The role of autophagy in the neurotoxicity of cationic PAMAM dendrimers. Biomaterials. 2014;35:7588–7597.
   PubMed Web of Science ®Google Scholar
• Mukherjee SP, Byrne HJ. Polyamidoamine dendrimer nanoparticle cytotoxicity, oxidative stress, caspase activation and inflammatory response: experimental observation and numerical simulation. Nanomedicine. 2013;9:202–211.
   PubMed Web of Science ®Google Scholar
• Akhtar S, Chandrasekhar B, Attur S, et al. On the nanotoxicity of PAMAM dendrimers: Superfect® stimulates the EGFR-ERK1/2 signal transduction pathway via an oxidative stress-dependent mechanism in HEK 293 cells. Int J Pharm. 2013;448:239–246.
   PubMed Web of Science ®Google Scholar
• Pryor JB, Harper BJ, Harper SL. Comparative toxicological assessment of PAMAM and thiophosphoryl dendrimers using embryonic zebrafish. Int J Nanomed. 2014;9:1947–1956.
   PubMed Web of Science ®Google Scholar
• Halets I, Shcharbin D, Klajnert B, et al. Contribution of hydrophobicity, DNA and proteins to the cytotoxicity of cationic PAMAM dendrimers. Int J Pharm. 2013;454:1–3.
   PubMed Web of Science ®Google Scholar
• Thiagarajan G, Greish K, Ghandehari H. Charge affects the oral toxicity of poly(amidoamine) dendrimers. Eur J Pharm Biopharm. 2013;84:330–334.
   PubMed Web of Science ®Google Scholar
• Wang L, Erasquin UJ, Zhao M, et al. Stability, antimicrobial activity, and cytotoxicity of poly(amidoamine) dendrimers on titanium substrates. ACS Appl Mater Interfaces. 2011;3:2885–2894.
   PubMed Web of Science ®Google Scholar
• Wang B, Navath RS, Menjoge AR, et al. Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers. Int J Pharm. 2010;395:298–308.
   PubMed Web of Science ®Google Scholar
• Lopez AI, Reins RY, McDermott AM, et al. Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers. Mol Biosyst. 2009;5:1148–1156.
   PubMed Web of Science ®Google Scholar
• Calabretta M, Kumar A, McDermott A, et al. Antibacterial activities of poly(amidoamine) dendrimers terminated with amino and poly(ethylene glycol) groups. Biomacromolecules. 2007;8:1807–1811.
   PubMed Web of Science ®Google Scholar
• Choi YJ, Kang SJ, Kim YJ, et al. Comparative studies on the genotoxicity and cytotoxicity of polymeric gene carriers polyethylenimine (PEI) and polyamidoamine (PAMAM) dendrimer in Jurkat T-cells. Drug Chem Toxicol. 2010;33:357–366.
   PubMed Web of Science ®Google Scholar
• Jevprasesphant R, Penny J, Jalal R, et al. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm. 2003;252:263–266.
   PubMed Web of Science ®Google Scholar
• Berenyi S, Mihaly J, Wacha A, et al. A mechanistic view of lipid membrane disrupting effect of PAMAM dendrimers. Colloids Surf B Biointerfaces. 2014;118:164–171.
   PubMed Web of Science ®Google Scholar
• Roy B, Panda AK, Parimi S, et al. Physico-chemical studies on the interaction of dendrimers with lipid bilayers. 1. Effect of dendrimer generation and liposome surface charge. J Oleo Sci. 2014;63:1185–1193.
   PubMed Web of Science ®Google Scholar
• Akesson A, Bendtsen KM, Beherens MA, et al. The effect of PAMAM G6 dendrimers on the structure of lipid vesicles. Phys Chem Chem Phys. 2010;12:12267–12272.
   PubMed Web of Science ®Google Scholar
• Yanez Arteta M, Ainalem ML, Porcar L, et al. Interactions of PAMAM dendrimers with negatively charged model biomembranes. J Phys Chem B. 2014;118:12892–12906.
   PubMed Web of Science ®Google Scholar
• Kim Y, Kwak Y, Chang R. Free energy of PAMAM dendrimer adsorption onto model biological membranes. J Phys Chem B. 2014;118:6792–6802.
   PubMed Web of Science ®Google Scholar
• Nyitrai G, Keszthelyi T, Bota A, et al. Sodium selective ion channel formation in living cell membranes by polyamidoamine dendrimer. Biochim Biophys Acta. 2013;1828:1873–1880.
   PubMed Web of Science ®Google Scholar
• Mansour H, Zografi G. The relationship between water vapor absorption and desorption by phospholipids and bilayer phase transitions. J Pharm Sci. 2007;96:377.
   PubMed Web of Science ®Google Scholar
• Neville F, Ivankin A, Konovalov O, et al. A comparative study on the interactions of SMAP-29 with lipid monolayers. Biochim Biophys Acta. 2010;1798:851–860.
   PubMed Web of Science ®Google Scholar
• Clifton LA, Lad MD, Green RJ, et al. Single amino acid substitutions in puroindoline-b mutants influence lipid binding properties. Biochemistry. 2007;46:2260–2266.
   PubMed Web of Science ®Google Scholar
• Paiva D, Brezesinski G, Pereira Mdo C, et al. Langmuir monolayers of monocationic lipid mixed with cholesterol or fluorocholesterol: DNA adsorption studies. Langmuir. 2013;29:1920–1925.
   PubMed Web of Science ®Google Scholar
• Bohinc K, Brezesinski G, May S. Modeling the influence of adsorbed DNA on the lateral pressure and tilt transition of a zwitterionic lipid monolayer. Phys Chem Chem Phys. 2012;14:10613–10621.
   PubMed Web of Science ®Google Scholar
• Nowotarska SW, Nowotarski KJ, Friedman M, et al. Effect of structure on the interactions between five natural antimicrobial compounds and phospholipids of bacterial cell membrane on model monolayers. Molecules. 2014;19:7497–7515.
   PubMed Web of Science ®Google Scholar
• Lad MD, Birembaut F, Clifton LA, et al. Antimicrobial peptide-lipid binding interactions and binding selectivity. Biophys J. 2007;92:3575–3586.
   PubMed Web of Science ®Google Scholar
• Deleu M, Crowet JM, Nasir MN, et al. Complementary biophysical tools to investigate lipid specificity in the interaction between bioactive molecules and the plasma membrane: a review. Biochim Biophys Acta. 2014;1838:3171–3190.
   PubMed Web of Science ®Google Scholar
• Brezesinski G, Mohwald H. Langmuir monolayers to study interactions at model membrane surfaces. Adv Colloid Interface Sci. 2003;100:563–584.
   PubMed Web of Science ®Google Scholar
• Epand RM, Epand RF. Lipid domains in bacterial membranes and the action of antimicrobial agents. Biochim Biophys Acta Biomembr. 2009;1788:289–294.
   PubMed Web of Science ®Google Scholar
• Böhme U, Klenge A, Hänel B, et al. Counterion condensation and effective charge of PAMAM dendrimers. Polymers. 2011;3:812–819.
   Web of Science ®Google Scholar
• Maiti PK, Çaǧn T, Lin ST, et al. Effect of solvent and pH on the structure of PAMAM dendrimers. Macromolecules. 2005;38:979–991.
   Web of Science ®Google Scholar
• Bodewein L, Schmelter F, Di Fiore S, et al. Differences in toxicity of anionic and cationic PAMAM and PPI dendrimers in zebrafish embryos and cancer cell lines. Toxicol Appl Pharmacol. 2016;305:83–92.
   PubMed Web of Science ®Google Scholar
• Prieto MJ, Bacigalupe D, Pardini O, et al. Nanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agent. Int J Pharm. 2006;326:160–168.
   PubMed Web of Science ®Google Scholar
• Kirkpatrick GJ, Plumb JA, Sutcliffe OB, et al. Evaluation of anionic half generation 3.5–6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin. J Inorganic Biochem. 2011;105:1115–1122.
   PubMed Web of Science ®Google Scholar
• Sweet DM, Kolhatkar RB, Ray A, et al. Transepithelial transport of PEGylated anionic poly(amidoamine) dendrimers: implications for oral drug delivery. J Control Release. 2009;138:78–85.
   PubMed Web of Science ®Google Scholar
• Oddone N, Lecot N, Fernandez M, et al. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer. J Nanobiotechnol. 2016;14:45.
   PubMed Web of Science ®Google Scholar
• Yavuz B, Bozdag Pehlivan S, Sumer Bolu B, et al. Dexamethasone – PAMAM dendrimer conjugates for retinal delivery: preparation, characterization and in vivo evaluation. J Pharm Pharmacol. 2016;68:1010–1020.
   PubMed Web of Science ®Google Scholar
• Lombardo D, Calandra P, Bellocco E, et al. Effect of anionic and cationic polyamidoamine (PAMAM) dendrimers on a model lipid membrane. Biochim Biophys Acta. 2016;1858:2769–2777.
   PubMed Web of Science ®Google Scholar
• Keszthelyi T, Hollo G, Nyitrai G, et al. Bilayer charge reversal and modification of lipid organization by dendrimers as observed by sum-frequency vibrational spectroscopy. Langmuir. 2015;31:7815–7825.
   PubMed Web of Science ®Google Scholar
• Nowacka O, Shcharbin D, Klajnert-Maculewicz B, et al. Stabilizing effect of small concentrations of PAMAM dendrimers at the insulin aggregation. Colloids Surf B Biointerfaces. 2014;116:757–760.
   PubMed Web of Science ®Google Scholar
• Shcharbin D, Klajnert B, Bryszewska M. The effect of PAMAM dendrimers on human and bovine serum albumin at different pH and NaCl concentrations. J Biomater Sci Polym Ed. 2005;16:1081–1093.
   PubMed Web of Science ®Google Scholar
• Sanders MR, Clifton LA, Neylon C, et al. Selected wheat seed defense proteins exhibit competitive binding to model microbial lipid interfaces. J Agric Food Chem. 2013;61:6890–6900.
   PubMed Web of Science ®Google Scholar
• Arsenault M, Bedard S, Boulet-Audet M, et al. Study of the interaction of lactoferricin B with phospholipid monolayers and bilayers. Langmuir. 2010;26:3468–3478.
   PubMed Web of Science ®Google Scholar
• Maget-Dana R. The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their interactions with lipid membranes. Biochim Biophys Acta Biomembr. 1999;1462:109–140.
   PubMed Web of Science ®Google Scholar
• Majoros I, Williams C, Becker A, et al. Surface interaction and behavior of poly(amidoamine) dendrimers: deformability and lipid bilayer disruption. J Comp Theo Nano. 2009;6:1430–1436.
   Google Scholar
• Mecke A, Majoros IJ, Patri AK, et al. Lipid bilayer disruption by polycationic polymers: the roles of size and chemical functional group. Langmuir. 2005;21:10348–10354.
   PubMed Web of Science ®Google Scholar
• Mecke A, Uppuluri S, Sassanella TM, et al. Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem Phys Lipids. 2004;132:3–14.
   PubMed Web of Science ®Google Scholar
• Wang YL, Lu ZY, Laaksonen A. Specific binding structures of dendrimers on lipid bilayer membranes. Phys Chem Chem Phys. 2012;14:8348–8359.
   PubMed Web of Science ®Google Scholar
• Lee H, Larson RG. Coarse-grained molecular dynamics studies of the concentration and size dependence of fifth- and seventh-generation PAMAM dendrimers on pore formation in DMPC bilayer. J Phys Chem B. 2008;112:7778–7784.
   PubMed Web of Science ®Google Scholar
• Lee H, Larson RG. Molecular dynamics simulations of PAMAM dendrimer-induced pore formation in DPPC bilayers with a coarse-grained model. J Phys Chem B. 2006;110:18204–18211.
   PubMed Web of Science ®Google Scholar
• Evans K, Laszlo J, Compton D. Carboxyl-terminated PAMAM dendrimer interaction with 1-palmitoyl-2-oleoyl phosphocholine bilayers. Biochim Biophys Acta Biomembr. 2014;1838:445–455.
   PubMed Web of Science ®Google Scholar
• Karolczak K, Rozalska S, Wieczorek M, et al. Poly(amido)amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood-brain barrier permeability in streptozotocin diabetes in rats. Int J Pharm. 2012;436:508–518.
   PubMed Web of Science ®Google Scholar
• Li Y, Gu N. Computer simulation of the inclusion of hydrophobic nanoparticles into a lipid bilayer. J Nanosci Nanotech. 2010;10:7616–7619.
   PubMed Web of Science ®Google Scholar
• Wang B, Zhang L, Bae SC, et al. Nanoparticle-induced surface reconstruction of phospholipid membranes. Proc Natl Acad Sci USA. 2008;105:18171–18175.
   PubMed Web of Science ®Google Scholar
• Zheng X, Wang T, Jiang H, et al. Incorporation of Carvedilol into PAMAM-functionalized MWNTs as a sustained drug delivery system for enhanced dissolution and drug-loading capacity. Asian J Pharm Sci. 2013;8:278–286.
   Google Scholar
• Zolotarskaya OY, Xu L, Valerie K, et al. Click synthesis of a polyamidoamine dendrimer-based camptothecin prodrug. RSC Adv. 2015;5:58600–58608.
   PubMed Web of Science ®Google Scholar
• Pasut G, Veronese F. State of the art in PEGylation: the great versatility achieved after forty years of research. J Control Release. 2012;161:461–472.
   PubMed Web of Science ®Google Scholar
• Fruijtier-Pölloth C. Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products. Toxicology. 2005;214:1–38.
   PubMed Web of Science ®Google Scholar
• Massenburg D, Lentz B. Poly(ethylene glycol)-induced fusion and rupture of dipalmitoylphosphatidylcholine large, unilamellar extruded vesicles. Biochemistry. 1993;32:9172–9180.
   PubMed Web of Science ®Google Scholar
• Boni LT, Stewart TP, Hui SW. Alterations in phospholipid polymorphism by polyethylene glycol. J Membr Biol. 1984;80:91–104.
   PubMed Web of Science ®Google Scholar
• Avaritt BR, Swaan PW. Intracellular Ca2+ release mediates cationic but not anionic poly(amidoamine) (PAMAM) dendrimer-induced tight junction modulation. Pharm Res. 2014;31:2429–2438.
   PubMed Web of Science ®Google Scholar
• Petrache HI, Zemb T, Belloni L, et al. Salt screening and specific ion adsorption determine neutral-lipid membrane interactions. Proc Natl Acad Sci USA. 2006;103:7982–7987.
   PubMed Web of Science ®Google Scholar
• Lodish H. Intracellular ion environment and membrane electric potential. In: Lodish H, Berk A, Kaiser CA, et al., editors. Molecular cell biology. 7th ed. New York (NY): W.H. Freeman & Co Ltd; 2012. p. 483–494.
   Google Scholar
• Aronson PS, Boron WF, Boulpaep EL. Transport of solutes and water. In: Boron WF, Boulpaep EL, editors. Medical physiology: a cellular and molecular approach. 2nd ed. Philadelphia (PA): Saunders; 2012. p. 106–146.
   Google Scholar
• Zhao W, Rog T, Gurtovenko AA, et al. Atomic-scale structure and electrostatics of anionic palmitoyloleoylphosphatidylglycerol lipid bilayers with Na + counterions. Biophys J. 2007;92:1114–1124.
   PubMed Web of Science ®Google Scholar
• Nisato G, Ivkov R, Amis E. J. Size invariance of polyelectrolyte dendrimers. Macromolecules. 2000;33:4172–4176.
   Web of Science ®Google Scholar